NA89
NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
11/21/2019
Back to search
Official data from USPTO
VGXI
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: CombinedOffice: US
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
26
Latest update
11/21/2019
Classification
Registered
Trademark type
Combined
Nice classes
40, 42
Filing date
10/30/2008
Registration date
10/13/2009
Expiration date
-
Recommended action
Perform a full collision analysis and validate classes before any filing or trademark investment.
Next step
These are the details of the registration process. Even so, constant monitoring is what ensures peace of mind that your main asset remains protected.
Complete case details
Structured fields from the responsible authority and the official record.
Status date
11/21/2019
Last transaction
11/21/2019
Responsible office
United States Patent and Trademark Office
Status code
800
Official register
Principal Register
First use anywhere
09/20/2008
First use in commerce
09/20/2008
Drawing code
3
Owner type
03
Owner location
Plymouth Meeting, PA, US
Examiner
PEREZ, STEVEN
Law office
L10
Current location
GENERIC WEB UPDATE
Mark description
The mark consists of "VGXI" in all capital letters with five circles or dots arranged in a circle-like pattern over the "I", thus appearing to dot the "I".
Holders and representatives
Holders
INOVIO PHARMACEUTICALS, INC.
VGX Pharmaceuticals, Inc.
Representatives
Ryan D. Artis RIVERSIDE LAW LLP
Technical classification
Nice Classes
Class 40Class 42
Vienna Codes
No Vienna codes available.
Goods and services
Class 40
Custom manufacture of nucleic acids including DNA plasmids, and current good manufacturing practice (cGMP) quality nucleic acids including DNA plasmids, to the order or specification of others
Class 42
Testing, analysis and evaluation of the goods and services of others for the purpose of certification, namely, testing and analysis of current good manufacturing practice (cGMP) processes of others used in the production of nucleic acid molecules and testing and analysis of the nucleic acids molecules produced by such processes
Publications
History of USPTO decisions and trademark events.
26 publications found
RNL1
REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)
11/21/2019
89AG
REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
11/21/2019
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
11/21/2019
E89R
TEAS SECTION 8 & 9 RECEIVED
10/14/2019
REM2
COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
10/13/2018
NA85
NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
12/07/2015
C15A
REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
12/07/2015
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
12/07/2015
E815
TEAS SECTION 8 & 15 RECEIVED
10/13/2015
ASGN
AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
04/23/2014
R.PR
REGISTERED-PRINCIPAL REGISTER
10/13/2009
PUBO
PUBLISHED FOR OPPOSITION
07/28/2009
NPUB
NOTICE OF PUBLICATION
07/08/2009
PREV
LAW OFFICE PUBLICATION REVIEW COMPLETED
06/23/2009
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
06/19/2009
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
06/19/2009
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
06/19/2009
ALIE
ASSIGNED TO LIE
06/16/2009
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
06/11/2009
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
12/11/2008
GNRT
NON-FINAL ACTION E-MAILED
12/11/2008
CNRT
NON-FINAL ACTION WRITTEN
12/11/2008
DOCK
ASSIGNED TO EXAMINER
12/11/2008
MDSC
NOTICE OF DESIGN SEARCH CODE MAILED
11/04/2008
NWAP
NEW APPLICATION ENTERED
11/03/2008
Continuous trademark protection
Get notified about every new filing that threatens VGXI or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.